4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:原厂直采,平行进口,授权代理(蚂蚁淘为您服务)
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > peptide > 免疫法/ABR-215062(拉奎尼莫)/10mg 50mg 100mg/MC0022
商品详细免疫法/ABR-215062(拉奎尼莫)/10mg 50mg 100mg/MC0022
免疫法/ABR-215062(拉奎尼莫)/10mg 50mg 100mg/MC0022
免疫法/ABR-215062(拉奎尼莫)/10mg 50mg 100mg/MC0022
商品编号: MC0022
品牌: Immunoway
市场价: ¥3200.00
美元价: 1600.00
产地: 美国(厂家直采)
公司:
产品分类: 多肽合成
公司分类: peptide
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍

    ABR-215062 (Laquinimod)

    • Catalog No.:MC0022
    • Data Sheet
    • MSDS
    • Support
    • Description
    • References ( 0 )
    • Protocol
      • CasNo:
      • 248281-84-7
      • MolecularFormula:
      • C19H17ClN2O3
      • Purity:
      • 99%
      • Target:
      • Caspase
      • IC50:
      • No data
      • In Vitro:
      • Laquinimod reverses EAE and inhibits pathogenic T cell immune responses. Laquinimod reverses RR-EAE and inhibits inflammatory T cell responses via a direct effect on myeloid APC. Laquinimod alters myeloid APC subsets and inhibits Th1 and Th17 polarization of myelin-specific T cells. Laquinimod-induced type II (M2) monocytes reverse established EAE[1]. Laquinimod modulates the phenotype of B cells of healthy donors. Laquinimod modulates expression of markers related to regulatory capacity in B cells of RRMS patients. Laquinimod reduces IFNγ cytokine expression in CD4+ T cells[2].
      • In Vivo:
      • Laquinimod treatment inhibits donor myelin-specific T cells from transferring EAE to naive recipient mice. In vivo laquinimod treatment alters subpopulations of myeloid antigen presenting cells (APC) that include a decrease in CD11c+CD11b+CD4+ dendritic cells (DC) and an elevation of CD11bhiGr1hi monocytes[1].
      • Fields:
      • Laquinimod (ABR-215062) is a potent immunomodulator.
      • Specificity:
      • Target:Caspase. Fields: Laquinimod (ABR-215062) is a potent immunomodulator.
      • Source:
      • Rabbit
      • Dilution:
      • WB 1:500-2000
      • Concentration:
      • 99%
      • Storage Stability:
      • 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO
      • Other Name:
      • ABR215062, ABR 215062 (Laquinimod)
      • MolecularWeight(Da):
      • 356.8
      • References:
      • [1]. Schulze-Topphoff, Ulf., et al. Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity. PLoS One (2012), 7(3), e33797.[2]. Toubi E,
      • June 19-2018
      • WESTERN IMMUNOBLOTTING PROTOCOL
      • June 19-2018
      • IMMUNOHISTOCHEMISTRY-PARAFFIN PROTOCOL
      • June 19-2018
      • IMMUNOFLUORESCENCE PROTOCOL
      • September 08-2020
      • FLOW-CYTOMEYRT-PROTOCOL
      • July 13-2018
      • CELL-BASED-ELISA-PROTOCOL-FOR-ACETYL-PROTEIN
      • July 13-2018
      • CELL-BASED-ELISA-PROTOCOL-FOR-PHOSPHO-PROTEIN
      • July 13-2018
      • CELL-BASED-COLORIMETRIC-ELISA-PROTOCOL-FOR-TOTAL-PROTEIN
      • July 13-2018
      • Antibody-FAQs
      • Products Images
      品牌介绍
      ImmunowayImmunoWay Biotechnology,我们的使命是帮助世界各地的生命科学研究人员通过更好的产品和服务简化和加速他们的研究。我们专注于开发用于免疫学和细胞学检测的创新和可靠的产品。我们一直是开发高质量ELISA试剂盒,代谢检测试剂盒,抗体和抗体/蛋白质微阵列的先驱,参与癌症,细胞凋亡,细胞生长和信号转导。ImmunoWay Biotechnology,我们的使命是通过更好的产品和服务帮助世界各地的生命科学研究者简化和加速他们的研究。我们专注于开发创新和可靠的产品,用于免疫学和细胞学检测。我们一直是开发涉及癌症,细胞凋亡,细胞生长和信号转导的高质量ELISA试剂盒,代谢测定试剂盒,抗体和抗体/蛋白质微阵列的先驱。